Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy

This study is currently recruiting participants.
Verified October 2012 by California Pacific Medical Center Research Institute
Sponsor:
Collaborators:
University of California, Los Angeles
Northwestern University
Information provided by (Responsible Party):
Janak Shah, MD, California Pacific Medical Center Research Institute
ClinicalTrials.gov Identifier:
NCT01678391
First received: August 29, 2012
Last updated: October 17, 2012
Last verified: October 2012
  Purpose

To assess the feasibility and success of endoscopic ultrasound (EUS) directed biliary stone removal without use of fluoroscopy. Success for this study will be defined as the successful removal of all stones from the bile duct without the use of fluoroscopy. Fluoroscopy will only be used at the end of a presumed successful procedure to confirm that all stones are removed.


Condition Intervention
Common Bile Duct Calculi
Procedure: Common bile duct stone removal without fluoroscopy.

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by California Pacific Medical Center Research Institute:

Primary Outcome Measures:
  • Successful removal of all stones from the bile duct without the use of fluoroscopy. [ Time Frame: Up to 24 hours. ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: August 2012
Groups/Cohorts Assigned Interventions
Patients with common bile duct stones. Procedure: Common bile duct stone removal without fluoroscopy.
ERCP stone extraction technique without fluoroscopy involves: (1) catheter or catheter with wire access into the bile duct, (2) confirmation of biliary access with catheter aspiration of bile, (3) performance of endoscopic biliary sphincterotomy or balloon dilation to widen the bile duct opening to permit stone removal, (4) stone removal - number of stones seen on EUS should match the number removed.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with common bile duct stones.

Criteria

Inclusion Criteria:

  • Patients able to give informed consent
  • Patients referred to IES for the endoscopic evaluation and treatment of suspected bile duct stones

Exclusion Criteria:

  • Patients with >3 bile duct stones or with any stone >12mm on EUS
  • Patients with no bile duct stones on EUS
  • Patients with altered biliary anatomy (periampullary diverticulum, anomalous pancreatibiliary junction, altered surgical anatomy)
  • Patients who are pregnant or breast-feeding
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01678391

Contacts
Contact: Janak Shah, M.D. 415-600-1151
Contact: Steve Kane 415-600-1151 kanesd@sutterhealth.org

Locations
United States, California
California Pacific Medical Center Recruiting
San Francisco, California, United States, 94115
Contact: Janak Shah, M.D.     415-600-1151        
Contact: Steve Kane     415-600-1151        
Principal Investigator: Janak Shah, M.D.            
Sub-Investigator: Kenneth Binmoeller, M.D.            
Sub-Investigator: Yasser Bhat, M.D.            
Sponsors and Collaborators
California Pacific Medical Center Research Institute
University of California, Los Angeles
Northwestern University
  More Information

Publications:
Responsible Party: Janak Shah, MD, Director of Pancreatic and Biliary Endoscopy, California Pacific Medical Center Research Institute
ClinicalTrials.gov Identifier: NCT01678391     History of Changes
Other Study ID Numbers: 2012.065-1
Study First Received: August 29, 2012
Last Updated: October 17, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Calculi
Gallstones
Pathological Conditions, Anatomical
Cholelithiasis
Biliary Tract Diseases
Digestive System Diseases
Cholecystolithiasis
Gallbladder Diseases

ClinicalTrials.gov processed this record on May 21, 2013